Life-Sciences-Scandinavia.com
The Nordic Life Sciences Web Portal

This is a free web portal for the life sciences in the Nordic countries Denmark, Finland, Iceland, Norway and Sweden... » read more

Optibrium: Tim Hohm Director Commercial Strategy & BusDev (2020-02-17)
Tim Hohm to further develop Optibrium’s sales and business strategy for global market expansion Optibrium™, a developer of software for drug discovery, today announced the appointment of Dr Tim Hohm as Director of Commercial Strategy and Business Development...
Orion/Bayer: CHMP Recommends Darolutamide in Prostate Cancer (2020-01-31)
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended darolutamide, an androgen receptor inhibitor (ARi), for marketing authorization in the European Union (EU). The compound, which is developed jointly ...
Saga Diagnostics: Cancer CDx for Clinical Trials of Servier (2020-01-28)
SAGA Diagnostics AB, a cancer liquid biopsy and genomic testing company focused on precision oncology and non-invasive ultrasensitive monitoring of cancer patients, today announces it has entered service agreements with the international pharmaceutical company Serv...
Elypta’s €6.1m Seed Round Led by Industrifonden & Sciety (2020-01-23)
Elypta, the Swedish molecular diagnostics firm pioneering metabolism-based liquid biopsies, announced today that it has raised €6.1 million in a late seed funding round closing in December 2019 and led by Industrifonden and Sciety. Norrsken Foundation’s newly raise...
Orion/Bayer: Japan Approves Darolutamide for Prostate Cancer (2020-01-23)
The Japanese Ministry of Health, Labor and Welfare (MHLW) has granted marketing authorization for darolutamide, under the brand name Nubeqa®, for the treatment of men with non-metastatic castration-resistant prostate cancer (nmCRPC). The approval is based on the...
Quest Diagnostics Acquires Blueprint Genetics Oy (2020-01-22)
Together, Quest Diagnostics, the world’s leading provider of diagnostic information services, and Blueprint Genetics will broaden access to actionable insights in genetic and rare diseases, improving patient care and pharmaceutical drug research and development. Fi...
HepaRegenix Closes $11m Series B Round to Enter the Clinic (2020-01-21)
Preclinical data demonstrate efficacy of MKK4 inhibitors in liver regeneration and experimental acute and chronic liver disease models HepaRegeniX GmbH, a preclinical stage company developing a novel therapy for the treatment of acute and chronic liver disease...
Qlucore: €400k Rights Issue & Two New Board Members (2020-01-21)
Qlucore, a world leader in the development of bioinformatics software, is expanding into the area of precision medicine and precision diagnostics. In order to finance the expansion Qlucore has recently finalized a rights issue of 400k Euros and is pleased to announ...
Vivoryon & Nordic Bioscience Enter into R&D Collaboration (2020-01-14)
Vivoryon Therapeutics AG (Euronext Amsterdam: VVY, ISIN DE0007921835) and Nordic Bioscience, announced today an agreement to collaborate for the clinical development of PQ912 for Alzheimer’s Disease (AD). In addition to taking on the role as CRO (Clinical Research ...
NorthSea Therapeutics €36m Series B Round Led by venBio (2020-01-08)
> Two new US investors; lead investor, venBio Partners and Sofinnova Investments, join syndicate of existing investors > Richard Gaster, M.D., Ph.D., Principal at venBio Partners, and Maha Katabi, Ph.D., CFA, Partner at Sofinnova Investments join the Board > ...

Life-Sciences-Scandinavia.com is your doorway to the Nordic life sciences!

[LSS] provides free, up-to-date and structured access to

– News
– Products
– Persons
– Organisations
– Financings
– Collaborations

in the Scandinavian countries Denmark, Finland, Iceland, Norway and Sweden.

Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSS] is 100% Made in Germany!

Start here with the latest News!

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 650x65px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)